Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;24(5):329-31.
doi: 10.1007/BF00304768.

The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation

M L Slevin  1 , S P Joel, R Whomsley, K Devenport, V J Harvey, R J Osborne, P F Wrigley
Affiliations

The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation

M L Slevin et al. Cancer Chemother Pharmacol. 1989.

Abstract

The effect of dose on the bioavailability of oral etoposide was investigated in ten patients with malignant mesothelioma who received single-agent etoposide as part of a phase II study. Etoposide pharmacokinetics were studied in each patient at oral dose levels of 100, 200, 300, 400 and 600 mg. At doses above 200 mg, the AUC and peak concentrations of etoposide were substantially lower than predictions based on the 100-mg dose. This study confirms previous observations that etoposide absorption is dose-dependent and that a mean bioavailability of approximately 50% cannot be assumed at total oral doses greater than 200 mg.

PubMed Disclaimer

References

    1. Cancer Chemother Pharmacol. 1982;7(2-3):81-5 - PubMed
    1. Cancer Chemother Pharmacol. 1979;3(2):71-80 - PubMed
    1. J Pharmacol Methods. 1983 May;9(3):193-9 - PubMed
    1. Cancer Treat Rep. 1978 Mar;62(3):473-5 - PubMed
    1. J Clin Oncol. 1983 Nov;1(11):701-5 - PubMed